Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Free Cash Flow to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - FCF/OCF Historical data
| Date | Free Cash Flow | Free Cash Flow to Operating Cash Flow | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ -304.72K | 0% | $ -304.72K |
| 3/31/2025 | $ 243.28K | 100% | $ 243.28K |
| 12/31/2024 | $ -265.19K | 0% | $ -265.19K |
| 9/30/2024 | $ -2.98M | 0% | $ -2.98M |
| 6/30/2024 | $ -3.13M | 0% | $ -3.13M |
| 3/31/2024 | $ -2.73M | 0% | $ -2.73M |
| 12/31/2023 | $ -653.11K | 0% | $ -653.11K |
| 9/30/2023 | $ -532.85K | 0% | $ -532.85K |
| 6/30/2023 | $ -454.55K | 0% | $ -454.55K |
| 3/31/2023 | $ -302.97K | 0% | $ -302.97K |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) FCF/OCF stands at 0%.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average FCF/OCF has been 100%.
- The median FCF/OCF for ASPIRE BIOPHARMA HOLDINGS INC during this period was 100%
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest FCF/OCF over the past 5 years at 100%.
- The lowest FCF/OCF recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe 100%
Similar metrics to CF - Operations:
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow to Operating Cash Flow
[Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].FCF / CF - Operations
(=) FCF/OCF FCF/OCF for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: FCF [ $ -238.6K ] / CF - Operations [ $ -238.6K ]
(=) FCF/OCF [ 0% ] ASBP - Free Cash Flow to Operating Cash Flow, Last 5 years
100%
Minimum
Mar 31, 2025
100%
Maximum
Mar 31, 2025
100%
Average
100%
Median
FCF/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of FCF/OCF for companies in the Total Stock Market. The average FCF/OCF of the companies is 71.5% with a standard deviation of 29.04%.
The following table provides additional summary stats:
FCF/OCF in the Market:
| filtered constituents | 2.51K |
|---|---|
| min | -23% |
| max | 171.58% |
| average | 71.5% |
| median | 80.83% |
| std | 29.04% |